The first patients with heterozygous STAT3 GOF mutations described in 2014 by Flanagan et al. [73] had infantile diabetes and other early-onset autoimmune disorders, including juvenile-onset arthritis, type 1 diabetes, enteropathy, and thyroiditis. This evidence concerns the gene STAT3 and Autoimmunity.